SATTIN, SARA
SATTIN, SARA
Dipartimento di Chimica
1,2-Mannobioside Mimic : synthesis, DC-SIGN Interaction by NMR and Docking, and Antiviral Activity
2007 J.J. Reina, S. Sattin, D. Invernizzi, S. Mari, L. Martinez-Prats, G. Tabarani, F. Fieschi, R. Delgado, P.M. Nieto, J. Rojo, A. Bernardi
A glycomimetic compound inhibits DC-sign mediated HIV infection in cellular and cervical explant models
2011 A. Berzi, S. Sattin, J. Reina Martin, M. Sanchez-Navarro, J. Rojo, D. Trabattoni, P. Antonazzo, I. Cetin, A. Bernardi, M. Clerici
A Glycomimetic compound inhibits DC-SIGN mediated HIV infection in cellular and cervical explant models
2011 A. Berzi, S. Sattin, J.J. Reina Martin, M. Sanchez Navarro, J. Rojo, D. Trabattoni, P. Antonazzo, I. Cetin, A. Bernardi, M. Clerici
A linear trimannoside mimic inhibits DC-SIGN mediated HIV infection by polyvalent presentation
2010 A. Berzi, S. Sattin, M. Sanchez Navarro, J.F. Rojo, A. Bernardi, M. Clerici
A linear trimannoside mimic inhibits DC-SIGN mediated HIV infection by polyvalent presentation
2010 A.M.V. Berzi, S. Sattin, M. Sanchez Navarro, J. Rojo, P.G.M. Antonazzo, I. Cetin, A. Bernardi, M.S. Clerici
A linear trimannoside mimic inhibits DC-SIGN mediated HIV infection by polyvalent presentation
2010 A. Berzi, S. Sattin, M. Sanchez Navarro, J.F. Rojo, A. Bernardi, M. Clerici
Activation of Hsp90 enzymatic activity and conformational dynamics through rationally designed allosteric ligands
2015 S. Sattin, J. Tao, G. Vettoretti, E. Moroni, M. Pennati, A. Lopergolo, L. Morelli, A. Bugatti, A. Zuehlke, M. Moses, T. Prince, T. Kijima, K. Beebe, M. Rusnati, L. Neckers, N. Zaffaroni, D.A. Agard, A. Bernardi, G. Colombo
Allosteric modulators of Hsp90: design, synthesis and activity evaluation
2016 S. Sattin, E. Moroni, J. Tao, F. Vasile, D. Agard, A. Bernardi, G. Colombo
An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC–SIGN) inhibitors of human dendritic cell adhesion
2010 N. Obermajer, U. Švajger, M. Jeras, S. Sattin, A. Bernardi, M. Anderluh
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2
2021 C. Cassiano, E. Morretta, M. Costantini, E.M.A. Fassi, G. Colombo, S. Sattin, A. Casapullo
Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22
2021 C. Di Carluccio, R. Ester Forgione, M. Montefiori, M. Civera, S. Sattin, G. Smaldone, K. Fukase, Y. Manabe, P.R. Crocker, A. Molinaro, R. Marchetti, A. Silipo
Benzofuran Derivatives Activators of the Chaperone Protein Hsp90: Synthesis, Interaction Studies and Biological Effects
2016 S. Sattin, J. Tao, F. Vasile, E. Moroni, D.A. Agard, A. Bernardi, G. Colombo
Benzofurans as allosteric activators of Hsp90 ATPase activity
2014 S. Sattin, L. Morelli, M. Panza, G. Vettoretti, E. Moroni, J. Tao, D. Agard, G. Colombo, A. Bernardi
Carbohydrates: a phenol sandwich fights diabetes
2015 A. Bernardi, S. Sattin
Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
2017 M. Bagdany, G. Veit, R. Fukuda, R.G. Avramescu, T. Okiyoneda, I. Baaklini, J. Singh, G. Sovak, H. Xu, P.M. Apaja, S. Sattin, L.K. Beitel, A. Roldan, G. Colombo, W. Balch, J.C. Young, G.L. Lukacs
Chemical and Biophysical Approaches to Allosteric Modulation
2021 M. Civera, E. Moroni, L. Sorrentino, F. Vasile, S. Sattin
Conformationally Constrained Sialyl Analogues as New Potential Binders of h-CD22
2022 R.E. Forgione, F.F. Nieto, C. Di Carluccio, F. Milanesi, M. Fruscella, F. Papi, C. Nativi, A. Molinaro, P. Palladino, S. Scarano, M. Minunni, M. Montefiori, M. Civera, S. Sattin, O. Francesconi, R. Marchetti, A. Silipo
DC-SIGN as a Target for Drug Development Based on Carbohydrates
2015 S. Sattin, F. Fieschi, A. Bernardi
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
2021 M. Thépaut, J. Luczkowiak, C. Vivès, N. Labiod, I. Bally, F. Lasala, Y. Grimoire, D. Fenel, S. Sattin, N. Thielens, G. Schoehn, A. Bernardi, R. Delgado, F. Fieschi
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
2020 M. Thépaut, J. Luczkowiak, C. Vivès, N. Labiod, I. Bally, F. Lasala, Y. Grimoire, D. Fenel, S. Sattin, N. Thielens, G. Schoehn, A. Bernardi, R. Delgado, F. Fieschi